Rosas PM

Language: Spanish
References: 12
Page: 230-233
PDF size: 52.46 Kb.

Text Extraction

No abstract

REFERENCES

1. Velázquez Monroy O, Rosas Peralta M, Lara Esqueda A, Pastelín Hernandez G, Attie F, Tapia Conyer R: Hipertensión Arterial en México: Resultados de la encuesta nacional de salud 2000. Arch Cardiol Mex 2002; 72: 71-84.

2. Velázquez Monroy O, Rosas Peralta M, Lara Esqueda A, Pastelín Hernández G, Attie F, Tapia Conyer R: Prevalencia e Interrelación de Enfermedades Crónicas No Trasmisibles y Factores de riesgo Cardiovascular en México. Resultados Finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2003; 73: 62-77.

3. Lara EA, Rosas PM, et al: Hipercolesterolemia e Hipertensión en México. Arch Cardiol Mex 2004; 74: 231-245.

4. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.

5. Pyorala K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2: 131-141.

6. Ninomiya JK, L’Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS: Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004; 109: 42-46.

7. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.

8. Festa A, D’Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47.

9. Klein BE, Klein R, Lee KE: Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002; 25: 1790-1794.

10. Dandona P, Aljada A, Mohanty P: The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 2002; 45: 924-930.

11. Rosas M, Pastelin G, Martinez Reding J, Herrera-Acosta J, Attie F: Comité Institucional para el Estudio y Prevención de la Hipertensión Arterial Sistémica. Hypertension guidelines in Mexico. Arch Cardiol Mex 2004; 74(2): 134-57.

12. International Diabetes Federation. The Consensus Worldwide Definition of the Metabolic Syndrome. Berlin, Alemania, April 2005. www.idf.org